What is SGT-280?
SGT-280 (Cumyl-CBMICA) is a newly researched synthetic cannabinoid. It was first discovered in August 2019 and later defined in 2020 as a new psychoactive substance (NPS). It was studied as a synthetic cannabinoid receptor agonist (SCRA) but defied the definition upon discovery, as SGT 280 has a unique side chain. Beyond the side chain, it closely mimics the SCRA Cumyl-PICA.
In theory, the synthetic cannabinoid is thought to have strong psychoactive properties.
This product isn’t approved for human consumption; it is for laboratory-based usage. To avoid any accidental contamination, always wear gloves and goggles when handling, as humans can absorb harmful amounts of chemicals through the skin.
This product isn’t approved for animal consumption and should be kept out of reach of animals.
SGT 280 should be handled safely to avoid inhalation.
SGT 280 is a newly researched synthetic cannabinoid. The current effects and properties of this chemical are unlisted and subject to change. Research and handle with caution.
How to Use SGT-280?
SGT 280 contains a unique side chain of cyclobutyl methyl but is otherwise identical to Cumyl-PICA. Its formula is 1-(cyclobutyl methyl)-N-(2-phenylpropanoid-2-yl)-1H-indole-3-carboxamide (C23H26N2O) with a formula weight of 346.5 and a molar mass of 346.474 g·mol−1. It’s a crystalline solid and requires storage at -20°C.
SGT 280 is still being researched. Specific details on this drug are subject to change.
Where to Buy?
Multiplescaners is the number one source for chemicals and drugs like 280 SGT on the market. Our products are ideal for research and laboratory use and ship quickly worldwide. We offer a variety of product types, but if you can’t find the form (powder, pellet, etc.) desired, contact us for help. You must be 18 years or older to buy SGT 280 and other products from our store.
You can buy SGT 280 in powder form directly from our site, with strength from 1g to 250g.
During its discovery, 280 SGT was monitored by the European Monitoring Centre for Drug and Drug Addiction (EMCDDA). It is currently governed under the German NpSG law, which covers other researched SCRA’s. In the UK, it’s classified as a Class B drug. 280 SGT is currently only approved for industrial and research use. read more